ChromoCure, Inc.
ChromoCure, Inc. (KKUR) PE Ratio — Current & Historical Data
Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.
kkur · pe ratio · data through Jun 10, 2026
Core PE Ratio Metrics
Trailing 12 months · TTMInsufficient PE history data (fewer than 3 valid fiscal years).
PE Ratio vs Peers
Medical - Specialties · 6 peers · Annual PE| Company | Market Cap | PE (Annual) | vs Avg | EPS (TTM) |
|---|---|---|---|---|
ChromoCure, Inc.You KKUR | $0M | N/A | — | — |
 Accelera Innovations, Inc ACNV | $0M | N/A | — | -$0.04 |
 Alternate Health Corp. AHGIF | $0M | N/A | — | -$0.44 |
 Biostax Corp. BTAX | $0M | N/A | — | -$0.03 |
 Ceres Ventures, Inc. CEVE | $0M | N/A | — | -$0.01 |
 GSRX Industries Inc. GSRX | $0M | N/A | — | -$0.56 |
 HST Global, Inc. HSTC | $30M | N/A | — | -$0.01 |
* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio
About PE Ratio & Methodology
The price-to-earnings (P/E) ratio for ChromoCure, Inc. (KKUR) measures how much investors pay for each dollar of the company's trailing earnings. KKUR's current PE ratio of N/A is calculated by dividing its stock price of $0.00 by its TTM earnings per share of —.
Frequently asked questions
KKUR pe ratio · 6 questionsKKUR's current PE ratio is N/A as of 2026-06-10, based on a stock price of $0.00 and TTM EPS of —. Data sourced from Financial Modeling Prep via KKUR's SEC 10-K and 10-Q filings.
▸ Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · ChromoCure, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-10